Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00622180 · ClinicalTrials.gov registry record · NA

The Efficacy of Hand Narrow-Band Ultraviolet B (NBUVB) Versus Excilite Treatment in Vitiligo After Minigrafting on the Dorsal Hands

A NA study, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT00622180 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 13 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00622180, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

To assess over a 25-week period the efficacy of hand-foot narrow-band ultraviolet B light versus focal 308-nm light treatment in inducing the return of pigment in vitiligo after skin minigraft transplants to the backs of the hands in patients with light brown to black skin. Subject will undergo treatment for 13 weeks.

Interventions

  • DEVICE NBUVB
  • DEVICE Monochromacitc Excimer light

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2008-01
Est. Completion 2009-03
Phase NA

What the Registry Record Tells You About NCT00622180

The ClinicalTrials.gov registry entry for NCT00622180 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which NBUVB is the first listed.

NCT00622180 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00622180 about?

NCT00622180 is a clinical study titled "The Efficacy of Hand Narrow-Band Ultraviolet B (NBUVB) Versus Excilite Treatment in Vitiligo After Minigrafting on the Dorsal Hands". To assess over a 25-week period the efficacy of hand-foot narrow-band ultraviolet B light versus focal 308-nm light treatment in inducing the return of pigment in vitiligo after skin minigraft transplants to the backs of the hands in patients with light brown to black skin. Subject will undergo trea...

What is the current status of trial NCT00622180?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2008-01. Estimated completion is 2009-03.

What interventions are being tested in trial NCT00622180?

The interventions under investigation include: NBUVB (DEVICE), Monochromacitc Excimer light (DEVICE).

Who is sponsoring clinical trial NCT00622180?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.